Regulatory News
Tuesday, April 12, 2016
FDA panel asks for more data on Clovis' lung cancer drug
April 12 (Reuters) - An independent panel of experts to the
U.S. Food and Drug Administration on Tuesday asked Clovis
Oncology Inc for more data on its lung cancer drug
before making a final decision...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment